Australian and New Zealand Intensive Care Foundation
Concentration RiskGiving Philosophy
The Foundation supports projects that advance intensive care medicine through research funding, education programs, and professional development opportunities. It values projects that demonstrate potential for significant impact on patient outcomes and that help researchers leverage additional funding from major granting bodies.
Tips for Applicants
Focus on research projects and education initiatives that directly improve intensive care outcomes. Applications should demonstrate clear potential for improving patient survival rates or quality of life, and show how the project can attract additional funding from major granting bodies.
Programs & Opportunities (5)
Development of educational products, learning packages, videos and online resources for critically ill patient care in ICU
Scholarships for early career clinician educators to enhance skills or qualifications in health professional education
Seed funding for research projects with emphasis on early career investigators, supporting pilot projects capable of major grant success
Projects developing or assessing new bedside devices or technologies to improve ICU patient outcomes
Research into intensive care therapies that support the respiratory system including ventilators, oxygen delivery systems, or respiratory drugs
Notable Grants
- Over $225,000 awarded to 8 recipients in 2025 representing medicine, nursing and allied health across Australia and NZ
- Almost $5M awarded across 140+ projects over 30 years
- Supported researchers have secured >$200M in follow-on funding from major granting bodies
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $442K | $499K | $2.7M | $68K |
| 2022 | $331K | $464K | $2.6M | $-112,414 |
| 2021 | $353K | $285K | $2.7M | $68K |
| 2020 | $437K | $396K | $2.4M | $41K |
| 2019 | $156K | $264K | $2.4M | $2K |
| 2018 | $275K | $415K | $2.4M | $-139,930 |
| 2017 | $376K | $362K | $2.5M | $14K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-80130947581
- ABN
- 80130947581
- Financial Year
- 2023
Focus Areas
Board & Leadership (8)
- David Zermanboard member
- David Zerman AMboard member
- Edward Littonchair
- Rachael Parkechair
- David Tuxendirector
- Jessica Schultsdirector
- Shay McGuinnessdirector
- Qi Chenofficeholder
Financials
- Revenue
- $442K
- Assets
- $2.7M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 16
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 3181
- Locality
- PRAHRAN
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 9/10
- LGA
- Port Phillip
- SA2 Region
- Prahran - Windsor
- Entities in Area
- 212